The UK has approved a COVID vaccine — here’s what scientists now want to know

Heidi Ledford, David Cyranoski and Richard Van Noorden

Nature, 2020, vol. 588, issue 7837, 205-206

Abstract: The Pfizer–BioNTech vaccine has passed safety and efficacy tests — but researchers still have many questions about how this and other vaccines will perform as they’re rolled out to millions of people.

Keywords: Vaccines; SARS-CoV-2 (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (10)

Downloads: (external link)
https://www.nature.com/articles/d41586-020-03441-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:588:y:2020:i:7837:d:10.1038_d41586-020-03441-8

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-03441-8

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().